HY-P99181-1mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-P99181-10mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-P99181-5mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-112615-1mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112615-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112615-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 1 [CAS 2241019-57-6]
|
|
Cancer-programmed cell death
|
|
HY-112616-10mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-100mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-25mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-5mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-112616-50mg
|
MedChemexpress LLC
|
NAMPT inhibitor-linker 2 [CAS 2241014-82-2]
|
|
Cancer-programmed cell death
|
|
HY-P99376-1mg
|
MedChemexpress LLC
|
Narsoplimab [CAS 2108782-45-0]
|
|
COVID-19-anti-virus
|
|
HY-P99376-10mg
|
MedChemexpress LLC
|
Narsoplimab [CAS 2108782-45-0]
|
|
COVID-19-anti-virus
|
|
HY-P99376-5mg
|
MedChemexpress LLC
|
Narsoplimab [CAS 2108782-45-0]
|
|
COVID-19-anti-virus
|
|
HY-P99750-1mg
|
MedChemexpress LLC
|
Navivumab [CAS 1443004-16-7]
|
|
|
|
HY-P99750-10mg
|
MedChemexpress LLC
|
Navivumab [CAS 1443004-16-7]
|
|
|
|
HY-P99750-5mg
|
MedChemexpress LLC
|
Navivumab [CAS 1443004-16-7]
|
|
|
|
HY-113764-10mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-100mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-25mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-5mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-50mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-1mL
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-P99756-1mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
HY-P99756-10mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|